Order Description
TASK:
Pfizer and Allergan Deal
Majority observers and stakeholders believe that the pending merger between Pfizer and Allergan is positive. However, there is a counter argument that holds the view that this merger is negative- where the risk exposure outweighs the proposed benefits.
With this outlook, provide a critical analysis of the $160 billion merger of Pfizer and Allergan. The analysis should consider but not be limited to industry dynamics; strategy; competition; structure of the deal as well as the challenges the new combined firm may face.
What is your considered opinion on the deal?
Guidelines
The narrative and assertions should be supported by factual evidence. In the absence of factual evidence, provide justifiable conclusions.
Conclusions and recommendations must be as a result of a critical evaluation that uses multiple citations and perspectives.
Descriptive narratives MUST be avoided as they do not offer any depth of argument.